Assignee
SUTRO BIOPHARMA INC
US·52 granted patents·45 pending applications·300 citations·filing 2010–2025
Top patents by PatentIndex Score
97 records- 0197US9840493B2Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Dec 12, 2017·24 cites·9 claims
- 0297US9682934B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2013·Granted Jun 20, 2017·35 cites·35 claims
- 0395US10112900B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·12 cites·13 claims
- 0495US9988619B2Non-natural amino acid tRNA synthetases for pyridyl tetrazineSUTRO BIOPHARMA INC·Filed 2014·Granted Jun 5, 2018·40 cites·10 claims
- 0594US10596270B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2018·Granted Mar 24, 2020·15 cites·24 claims
- 0694US9938516B2Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanineSUTRO BIOPHARMA INC·Filed 2014·Granted Apr 10, 2018·40 cites·22 claims
- 0794US9764039B2Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Sep 19, 2017·20 cites·36 claims
- 0893US10450353B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 22, 2019·6 cites·13 claims
- 0992US11744876B2Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2020·Granted Sep 5, 2023·4 cites·47 claims
- 1092US10774354B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2018·Granted Sep 15, 2020·9 cites·29 claims
- 1192US10669347B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·5 cites·16 claims
- 1292US10442789B2Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 15, 2019·4 cites·11 claims
- 1392US9738724B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 22, 2017·12 cites·35 claims
- 1491US10190145B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2014·Granted Jan 29, 2019·12 cites·20 claims
- 1591US10179909B2Non-natural amino acid tRNA synthetases for pyridyl tetrazineSUTRO BIOPHARMA INC·Filed 2018·Granted Jan 15, 2019·5 cites·10 claims
- 1691US9994527B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 12, 2018·6 cites·15 claims
- 1791US9732161B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 15, 2017·7 cites·20 claims
- 1890US11261219B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 1, 2022·4 cites·15 claims
- 1989US10730837B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·27 claims
- 2089US9650621B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2013·Granted May 16, 2017·10 cites·13 claims
- 2188US12269801B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2022·Granted Apr 8, 2025·0 cites·17 claims
- 2288US11548852B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2020·Granted Jan 10, 2023·1 cites·26 claims
- 2388US10501558B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·20 claims
- 2487US10648010B2Formulations for drying bacterial cell extractsSUTRO BIOPHARMA INC·Filed 2016·Granted May 12, 2020·4 cites·19 claims
- 2584US2025236594A1Modified amino acidsSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2683US11958909B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2020·Granted Apr 16, 2024·1 cites·20 claims
- 2783US11408021B2Formulations for drying bacterial cell extractsSUTRO BIOPHARMA INC·Filed 2020·Granted Aug 9, 2022·1 cites·10 claims
- 2883US2025002604A1Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2982US11708413B2Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2017·Granted Jul 25, 2023·3 cites·29 claims
- 3082US10316322B2High growth capacity auxotrophic Escherichia coli and methods of useSUTRO BIOPHARMA INC·Filed 2015·Granted Jun 11, 2019·4 cites·23 claims
- 3182US2025090676A1Anti-folate receptor alpha antibody conjugates and their usesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3281US11098107B2Antibodies with engineered CH2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2017·Granted Aug 24, 2021·2 cites·25 claims
- 3381US2025346650A1Antibodies with engineered ch2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 3479US10487133B2Codon optimization for titer and fidelity improvementSUTRO BIOPHARMA INC·Filed 2015·Granted Nov 26, 2019·2 cites·26 claims
- 3578US2024254163A1Hemiasterlin derivatives for conjugation and therapySUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3677US12144869B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·0 cites·24 claims
- 3777US12098406B2Formulations for drying bacterial cell extractsSUTRO BIOPHARMA INC·Filed 2022·Granted Sep 24, 2024·0 cites·28 claims
- 3877US9896685B2Use of LAMBDA-GAM protein in ribosomal display technologySUTRO BIOPHARMA INC·Filed 2014·Granted Feb 20, 2018·1 cites·9 claims
- 3977US2024010715A1Antibodies with engineered ch2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 4077US2025018054A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4175US12226490B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary classSUTRO BIOPHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·38 claims
- 4275US11407975B2E. coli strains having an oxidative cytoplasmSUTRO BIOPHARMA INC·Filed 2019·Granted Aug 9, 2022·1 cites·29 claims
- 4374US11993658B2Anti-BCMA antibodies and treatment methodsSUTRO BIOPHARMA INC·Filed 2019·Granted May 28, 2024·1 cites·16 claims
- 4474US2025304723A1Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 4573US2024409630A1Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodiesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4672US12427201B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2019·Granted Sep 30, 2025·0 cites·27 claims
- 4772US12398197B2Antibodies with engineered CH2 domains, compositions thereof and methods of using the sameSUTRO BIOPHARMA INC·Filed 2021·Granted Aug 26, 2025·0 cites·16 claims
- 4872US12252552B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 18, 2025·0 cites·32 claims
- 4972US10844090B2Hemiasterlin derivatives for conjugation and therapySUTRO BIOPHARMA INC·Filed 2016·Granted Nov 24, 2020·1 cites·16 claims
- 5072US2026078337A1E. coli strains having an oxidative cytoplasmSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SUTRO BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →